Valeur202020212022202320242025TTMFrais de vente, généraux et administratifs743.57 M860.09 M863.75 M929.87 M995.27 M720.17 M793.27 MRecherche et développement119.75 M130.84 M153.82 M154.35 M161.67 M144.78 M163.87 MRésultat d'exploitation423.07 M628.1 M499.73 M506.31 M151.01 M118.37 M-219.53 MTotal des produits hors exploitation20.34 M20.62 M21.79 M-13.65 M-107.31 M28.62 M32.48 MCharges d'intérêts, nettes des intérêts capitalisés66.49 M56.97 M54.26 M85.08 M83.54 M100.22 M107.4 MRésultat hors exploitation, hors charges d'intérêts-46.16 M-36.34 M-32.47 M-98.73 M-190.86 M-71.6 M-74.92 MRevenus/dépenses exceptionnels———————Résultat avant impôts357.73 M559.47 M445.92 M434.01 M75.48 M24.55 M-38.02 MPart des actionnaires dans le résultat———————Impôts21.93 M74.35 M83 M76.44 M5.32 M-33.98 M-39.38 MIntérêts ne donnant pas le contrôle / intérêts minoritaires———————Autres produits/charges après impôts———————Résultat net avant activités abandonnées335.8 M485.12 M362.92 M357.57 M70.16 M58.53 M-294.68 MActivités abandonnées-477 K255 K223 K-1.24 M-487 K-964.17 M-714.11 MRésultat net335.32 M485.37 M363.14 M356.33 M69.67 M-905.64 M-1.01 BAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires335.32 M485.37 M363.14 M356.33 M69.67 M-905.64 M-1.01 BBénéfice par action de base (BPA de base)7.2110.387.747.581.49-20.3-22.8Bénéfice par action dilué (BPA dilué)7.0910.237.687.531.48-20.25-22.8Nombre moyen d'actions de base en circulation46.49 M46.77 M46.9 M46.98 M46.84 M44.62 M—Nombre d'actions en circulation après dilution47.29 M47.43 M47.31 M47.3 M47.09 M44.72 M—EBITDA427.5 M632.59 M503.78 M615.8 M659.89 M127.87 M1.28 BEBIT195.82 M390.73 M269.13 M279.8 M116.41 M-54.54 M816.99 MCoût des ventes1.21 B1.26 B1.26 B1.33 B1.34 B871.96 M801.57 MAutres coûts des ventes———————Amortissements (flux de trésorerie)231.68 M241.85 M234.64 M245.52 M278.02 M182.41 M465.06 M
Teleflex Incorporated Common Stock
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with Irish corporate tax avoidance tools. Teleflex's chief executive officer is Liam J. Kelly; Kelly is also the company's president and former chief operating officer.